Skip to main content

Table 1 Comparison of characteristics of participants across three groups

From: Exploring serum miR-33b as a novel diagnostic marker for hypercholesterolemia and obesity: insights from a pilot case-control study

Ā 

Total

Healthy

HC

Obese

p-value

N = 45

N = 15

N = 15

N = 15

History of hyperlipidemia, n (%)

9 (20.00)

2 (13.33)

5 (33.33)

2 (13.33)

0.11

Taking anti-hyperlipidemic drug, n (%)

4 (44.44)

2 (13.30)

10 (66.70)

2 (13.30)

0.01

History of cardiovascular disease, n (%)

4 (8.89)

0 (0.00)

2 (13.33)

2 (13.33)

0.33

Taking anti-hypertensive drug, n (%)

7 (15.56)

1 (6.67)

3 (20.00)

3 (20.00)

0.51

Taking anti-diabetic drug, n (%)

3 (6.67)

0 (0.00)

2 (13.33)

1 (6.67)

0.34

Current smoker, n (%)

6 (13.33)

2 (13.33)

2 (13.33)

2 (13.33)

1.00

Low physical activity, n (%)

18 (40.00)

4 (26.67)

8 (53.33)

6 (40.00)

0.27

  1. Data are presented as n (%) for categorical measures using Chi-square test